Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy

Epilepsia

Volumn 51, Issue 12, 2010, Pages 2500-2502

  Wegner, Ilse ^a   Edelbroek, Peter ^a   De Haan, Gerrit Jan ^a   Lindhout, Dick ^a,b   Sander, Josemir W ^a,c  

^a STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Epilepsy; Lamotrigine; Oxcarbazepine; Pharmacokinetics; Pregnancy

Indexed keywords

LAMOTRIGINE; LICARBAZEPINE; OXCARBAZEPINE; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; HUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SPOTTING; STEADY STATE;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; METABOLIC CLEARANCE RATE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; TRIAZINES;

EID: 78650033612     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02771.x     Document Type: Article

References (13)

1. Christensen J, Sabers A, Sidenius P. (2006) Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy. Neurology 67: 1497-1499.
2. De Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Dévilé-Notschaele M, Augustijn P. (2004) Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology 63: 571-573.
3. Johannessen Landmark C, Patsalos PN. (2010) Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother 10: 1119-1140.
4. Kramer G, Dorn T, Etter H. (2003) Oxcarbazepine: clinically relevant drug interaction with lamotrigine. Epilepsia 44 (Suppl 9): 95-96. Abstract.
5. Mazzucchelli I, Onat FY, Ozkara C, Atakli D, Specchio LM, La Neve A, Gatti G, Perucca E. (2006) Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. Epilepsia 47: 504-509.
6. Öhman I, Beck O, Vitols S, Tomson T. (2008) Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia 49: 1075-1080.
7. Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. (2004) The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology 62: 292-295.
8. Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, Newman RN, Stowe ZN. (2008) Lamotrigine in pregnancy. Clearance, therapeutic drug monitoring, and seizure frequency. Neurology 70: 2130-2136.
9. Petrenaite V, Sabers A, Hansen-Schwartz J. (2009) Seizure deterioration in women treated with oxcarbazepine during pregnancy. Epilepsy Res 84: 245-249.
10. Rowland A, Elliot DJ, Williams JA, Mackenzie PI, Dickinson RG, Miners JO. (2006) In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction. Drug Metab Dispos 34 (6): 1055-1062.
11. Tecoma ES. (1999) Oxcarbazepine. Epilepsia 40 (Suppl 5): S37-S46.
12. Tomson T, Battino D. (2007) Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 46: 209-219.
13. Vermeij TAC, Edelbroek PM. (2007) Robust isocratic high performance liquid chromatographic method for simultaneous determination of 7 antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction. J Chromatogr B 857: 40-46.